Published in Blood Weekly, December 23rd, 1996
The Ceprate SC System is indicated for purification of stem cells for bone-marrow transplantation. The Ceprate SC System is the first cell processing system approved by the FDA for this indication.
"Receipt of marketing approval and the U.S. launch of the Ceprate SC System are pivotal corporate accomplishments for CellPro that will help propel the development of future cell therapy products based on our core cell selection technology," said Richard Murdock, CellPro. "These...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.